Pila Pharma AB (publ)

Stockholm Stock Exchange PILA.ST

Pila Pharma AB (publ) Operating Cash Flow for the year ending December 31, 2023: USD -479.09 K

Pila Pharma AB (publ) Operating Cash Flow is USD -479.09 K for the year ending December 31, 2023. Operating cash flow is cash generated from the company’s regular business operations.

Pila Pharma AB (publ) Operating Cash Flow for the year ending December 31, 2021 was USD -1.03 M.
Pila Pharma AB (publ) Operating Cash Flow for the year ending December 31, 2019 was USD -534.45 K, a -4.10% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Stockholm Stock Exchange: PILA.ST

Pila Pharma AB (publ)

CEO	Mr. Gustav Hanghoj Gram
IPO Date	July 15, 2021
Location	Sweden
Headquarters	VAestergatan 1
Employees	1
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Clinical Trials Drugstores & Retail Pharmacies Vaccines

Description

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Key trends

Past 5 years